COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors.

Shukla, Shakti D; Walters, E Haydn

Shukla, Shakti D; Walters, E Haydn.

Shukla SD; Faculty of Health and Medicine, School of Medicine and Public Health, and Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, New South Wales, Australia.
Walters EH; Hunter Medical Research Institute, Newcastle, New South Wales, Australia.

Intern Med J ; 50(9): 1153-1154, 2020 09.

Article in English | MEDLINE | ID: covidwho-646951

Subject(s)

Coronavirus Infections/physiopathology; Pneumonia, Viral/physiopathology; Pulmonary Disease, Chronic Obstructive/physiopathology; Angiotensin-Converting Enzyme 2; Apoptosis Regulatory Proteins/metabolism; Betacoronavirus; COVID-19; Furin/metabolism; HSP70 Heat-Shock Proteins/metabolism; Humans; Membrane Proteins/metabolism; Pandemics; Peptidyl-Dipeptidase A/metabolism; Platelet Membrane Glycoproteins/antagonists & inhibitors; Receptors, G-Protein-Coupled/antagonists & inhibitors; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pulmonary Disease, Chronic Obstructive Type of study: Prognostic study Limits: Humans Language: English Journal: Intern Med J Journal subject: Internal Medicine Year: 2020 Document Type: Article Affiliation country: Imj.14887

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google